(Q35184850)

7 August 2017

1 reference

title

Looking to the future: diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes models (English)

1 reference

7 August 2017

1 reference

Norman Cameron

1

1 reference

7 August 2017

Mary Cotter

series ordinal

2

1 reference

7 August 2017

Melanie Inkster

series ordinal

3

1 reference

7 August 2017

Matthew Nangle

series ordinal

4

1 reference

7 August 2017

language of work or name

1 reference

1 July 2003

1 reference

Diabetes Research and Clinical Practice

7 August 2017

published in

1 reference

7 August 2017

volume

61 Suppl 1

1 reference

7 August 2017

page(s)

S35-9

1 reference

Metabolic and vascular factors in the pathogenesis of diabetic neuropathy

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900123-2

7 January 2021

Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900123-2

7 January 2021

A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900123-2

7 January 2021

Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900123-2

7 January 2021

Pathology and pathogenetic mechanisms of diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900123-2

7 January 2021

Experimental diabetic neuropathy: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900123-2

7 January 2021

The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900123-2

7 January 2021

Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900123-2

7 January 2021

The effects of treatment with alpha-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900123-2

7 January 2021

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900123-2

7 January 2021

Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900123-2

7 January 2021

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900123-2

7 January 2021

10.1016/S0168-8227(03)00123-2

Identifiers

DOI

1 reference

7 August 2017

1 reference